Cargando…
Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study
Background: Histologic activity has emerged as an aspirational therapeutic goal in ulcerative colitis management. It is not yet a formal treatment target in ulcerative colitis. However, it could be used as an adjunct to mucosal healing to represent a deeper level of healing. We investigated mucosal...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376510/ https://www.ncbi.nlm.nih.gov/pubmed/37509500 http://dx.doi.org/10.3390/biomedicines11071860 |
_version_ | 1785079288529158144 |
---|---|
author | State, Monica Balanescu, Paul Voiosu, Theodor Bengus, Andreea Voiosu, Andrei Coman, Andrei Mustatea, Petronel Negreanu, Lucian Mateescu, Radu Bogdan Popp, Cristiana |
author_facet | State, Monica Balanescu, Paul Voiosu, Theodor Bengus, Andreea Voiosu, Andrei Coman, Andrei Mustatea, Petronel Negreanu, Lucian Mateescu, Radu Bogdan Popp, Cristiana |
author_sort | State, Monica |
collection | PubMed |
description | Background: Histologic activity has emerged as an aspirational therapeutic goal in ulcerative colitis management. It is not yet a formal treatment target in ulcerative colitis. However, it could be used as an adjunct to mucosal healing to represent a deeper level of healing. We investigated mucosal and histologic remission rates and potential predictors of these outcomes in a cohort of UC patients. Methods: We conducted a retrospective analysis of data collected from UC patients enrolled in an ongoing prospective cohort study. Mucosal healing was defined as Mayo endoscopic score = 0. Results: A total of 131 patients with ulcerative colitis were enrolled in our study and were prospectively followed for a median length of 2 years (range 0–5 years), totaling 266 study visits. Mucosal healing was recorded for 27 patients at 70 (26%) different study visits. For patients with mucosal healing, histologic remission was achieved in 18/27 (66%) patients. On univariate analysis, sustained clinical remission, SIBDQ scores ≥ 5.5, CRP ≤ 5 mg/dL and absence of corticotherapy were associated with mucosal healing and SIBDQ scores ≥ 5.5 and CRP ≤ 5 mg/dL with histologic healing, respectively. After logistic regression analysis, none of the investigated factors were associated with mucosal and histologic healing. The number of CD8+ intraepithelial lymphocytes (IELs) was significantly greater than the number of CD4+ IELs in periods of disease activity, as well as during mucosal healing (p < 0.01 in both cases). Conclusions: Mucosal healing and histologic remission rates are low in real-life settings. The results of univariate analysis indicate that a good quality of life (SIBDQ score) and normal inflammatory markers (CRP) are associated with mucosal and histologic healing. However, frequently used patient- and disease-related factors, including mucosal healing, are not reliable predictors for histologic remission. Greater CD8+ lymphocyte involvement and higher CD8+/CD4+ distribution can have a meaningful impact on understanding the pathogenesis and natural history of ulcerative colitis, as well as future treatment options for lymphocyte-targeting medications. |
format | Online Article Text |
id | pubmed-10376510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103765102023-07-29 Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study State, Monica Balanescu, Paul Voiosu, Theodor Bengus, Andreea Voiosu, Andrei Coman, Andrei Mustatea, Petronel Negreanu, Lucian Mateescu, Radu Bogdan Popp, Cristiana Biomedicines Article Background: Histologic activity has emerged as an aspirational therapeutic goal in ulcerative colitis management. It is not yet a formal treatment target in ulcerative colitis. However, it could be used as an adjunct to mucosal healing to represent a deeper level of healing. We investigated mucosal and histologic remission rates and potential predictors of these outcomes in a cohort of UC patients. Methods: We conducted a retrospective analysis of data collected from UC patients enrolled in an ongoing prospective cohort study. Mucosal healing was defined as Mayo endoscopic score = 0. Results: A total of 131 patients with ulcerative colitis were enrolled in our study and were prospectively followed for a median length of 2 years (range 0–5 years), totaling 266 study visits. Mucosal healing was recorded for 27 patients at 70 (26%) different study visits. For patients with mucosal healing, histologic remission was achieved in 18/27 (66%) patients. On univariate analysis, sustained clinical remission, SIBDQ scores ≥ 5.5, CRP ≤ 5 mg/dL and absence of corticotherapy were associated with mucosal healing and SIBDQ scores ≥ 5.5 and CRP ≤ 5 mg/dL with histologic healing, respectively. After logistic regression analysis, none of the investigated factors were associated with mucosal and histologic healing. The number of CD8+ intraepithelial lymphocytes (IELs) was significantly greater than the number of CD4+ IELs in periods of disease activity, as well as during mucosal healing (p < 0.01 in both cases). Conclusions: Mucosal healing and histologic remission rates are low in real-life settings. The results of univariate analysis indicate that a good quality of life (SIBDQ score) and normal inflammatory markers (CRP) are associated with mucosal and histologic healing. However, frequently used patient- and disease-related factors, including mucosal healing, are not reliable predictors for histologic remission. Greater CD8+ lymphocyte involvement and higher CD8+/CD4+ distribution can have a meaningful impact on understanding the pathogenesis and natural history of ulcerative colitis, as well as future treatment options for lymphocyte-targeting medications. MDPI 2023-06-29 /pmc/articles/PMC10376510/ /pubmed/37509500 http://dx.doi.org/10.3390/biomedicines11071860 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article State, Monica Balanescu, Paul Voiosu, Theodor Bengus, Andreea Voiosu, Andrei Coman, Andrei Mustatea, Petronel Negreanu, Lucian Mateescu, Radu Bogdan Popp, Cristiana Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study |
title | Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study |
title_full | Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study |
title_fullStr | Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study |
title_full_unstemmed | Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study |
title_short | Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study |
title_sort | real-world endoscopic and histologic outcomes in ulcerative colitis patients: a retrospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376510/ https://www.ncbi.nlm.nih.gov/pubmed/37509500 http://dx.doi.org/10.3390/biomedicines11071860 |
work_keys_str_mv | AT statemonica realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT balanescupaul realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT voiosutheodor realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT bengusandreea realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT voiosuandrei realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT comanandrei realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT mustateapetronel realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT negreanulucian realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT mateescuradubogdan realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy AT poppcristiana realworldendoscopicandhistologicoutcomesinulcerativecolitispatientsaretrospectivecohortstudy |